ReviewNature and science of sleep2026
Intermittent Hypoxia-Induced Inflammation and the Formation of Exhaled Volatile Organic Compound Profiles in Obstructive Sleep Apnea-Hypopnea Syndrome: A Narrative Review.
Review in Nature and science of sleep, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obstructive sleep apnea-hypopnea syndrome (OSAHS) is characterized by recurrent upper airway obstruction during sleep, intermittent hypoxia (IH), and sleep fragmentation, and is associated with oxidative stress, chronic low-grade inflammation, metabolic dysregulation, and upper airway remodeling. These pathophysiological disturbances may alter the generation and release of volatile metabolites, thereby providing a rationale for investigating exhaled volatile organic compound (VOC) profiles as noninvasive indicators of OSAHS-related redox imbalance, inflammatory activity, and metabolic abnormalities. Focusing on IH-induced inflammatory responses as a central mechanistic link, this review examines the potential mechanisms through which inflammation contributes to changes in exhaled VOC profiles in OSAHS. Repeated hypoxia-reoxygenation and upper airway mechanical stress may activate inflammatory signaling pathways, including nuclear factor κB, hypoxia-inducible factor-1α, and NOD-like receptor family pyrin domain-containing 3, and may influence the generation and release of volatile metabolites such as aldehydes, alkanes, acetone, alcohols, and isoprene through amplified oxidative stress, lipid peroxidation, metabolic reprogramming, and alterations in the local airway microenvironment. Available clinical studies suggest that exhaled VOC profiles in patients with OSAHS may be associated with disease severity, nocturnal hypoxic burden, metabolic abnormalities, and treatment response. However, the specificity and reproducibility of candidate VOCs remain limited by individual metabolic profiles, exogenous exposures, and methodological heterogeneity. Future studies should integrate standardized breath sampling, high-confidence compound identification, longitudinal validation, and concurrent assessment of inflammatory, oxidative stress, and metabolic markers. Inflammation-related VOC profiling may offer mechanistic insight into the pathophysiological heterogeneity of OSAHS and support the development of noninvasive assessment tools and more personalized management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.